Monday, August 20, 2007
4:00 PM - 6:00 PM
Sheraton Seattle Hotel & Towers
Leading international researchers from the International AIDS Vaccine Initiative, the Medical Research Council in Uganda, the Centers for Disease Control and Prevention and the U.S. Military HIV Research Program will gather at the Seattle AIDS Vaccine Conference to discuss new data that could reshape the medical field's approach to conducting clinical trials in the developing world.
The results of several newly-released studies reveal how laboratory reference ranges from healthy clinically asymptomatic persons in East Africa differ from the Western standards used to qualify these individuals for participation in clinical trials to date. As a result, many potential volunteers in the developing world have been disqualified from studies that assess whether a vaccine or drug works in the population for which it is intended. These new ranges will help to improve participation in clinical trials to find better prevention strategies, treatments and cures for diseases most prevalent in the developing world and will help to enable research teams to better evaluate the health of volunteers throughout the course of a clinical trial.
Come join leading AIDS vaccine experts as they discuss the implications of this ground-breaking research.
Senior Director, Clinical Laboratory Development
International AIDS Vaccine Initiative
Protocol Chair and Epidemiologist
Medical Research Council/Uganda Virus Research Institute
Mark de Souza
Director, International Laboratory Program
U.S. Military HIV Research Program
Director, HIV Research Lab
Kenya Medical Research Institute/CDC Field Station, Kisumu, Kenya